A novel software tool set to improve the management of elderly atrial fibrillation patients with multiple conditions is being designed by the EU-funded and ESC-coordinated EHRA-PATHS consortium. The latest updates on this clinical innovation will be presented at EHRA 2023, a scientific congress of the European Society of Cardiology.
Data from the ETNA-AF-Europe Registry provide insights on edoxaban in clinical routine practice in subpopulations including frail patients and those with worsening renal function. ENVISAGE-TAVI